Tumor Necrosis Factor (TNF)

Introduction

Pathway Diagram

flowchart TD
    Tumor["Brain Tumor<br/>Pathogenesis"]
    
    TNF["TNF<br/>Pro-inflammatory<br/>Cytokine"]
    CGAS["cGAS<br/>DNA Sensor"]
    STING["STING<br/>Innate Immunity"]
    CD8["CD8+ T Cells<br/>Immune Response"]
    
    MYC["MYC<br/>Oncogene"]
    SRC["SRC<br/>Kinase"]
    EGFR["EGFR<br/>Growth Factor<br/>Receptor"]
    MTOR["mTOR<br/>Growth Signaling"]
    
    TP53["p53<br/>Tumor Suppressor"]
    PTEN["PTEN<br/>Tumor Suppressor"]
    
    STAT3["STAT3<br/>Transcription<br/>Factor"]
    JUN["c-JUN<br/>Transcription<br/>Factor"]
    NRF2["NRF2<br/>Antioxidant<br/>Response"]
    
    LC3["LC3<br/>Autophagy<br/>Marker"]
    SQSTM1["SQSTM1/p62<br/>Autophagy<br/>Adapter"]
    
    GBM["Glioblastoma<br/>Formation"]
    
    TNF -->|"activates"| Tumor
    CGAS -->|"activates"| STING
    STING -->|"activates"| Tumor
    CD8 -->|"suppresses"| Tumor
    
    MYC -->|"promotes"| Tumor
    SRC -->|"activates"| Tumor
    EGFR -->|"activates"| MTOR
    MTOR -->|"promotes"| Tumor
    
    TP53 -->|"suppresses"| Tumor
    PTEN -->|"suppresses"| Tumor
    
    STAT3 -->|"promotes"| Tumor
    JUN -->|"promotes"| Tumor
    NRF2 -->|"promotes"| Tumor
    
    LC3 -->|"regulates"| Tumor
    SQSTM1 -->|"promotes"| Tumor
    
    Tumor -->|"progresses_to"| GBM
    
    style Tumor fill:#006494
    style CD8 fill:#1b5e20
    style TP53 fill:#1b5e20
    style PTEN fill:#1b5e20
    style TNF fill:#ef5350
    style MYC fill:#ef5350
    style SRC fill:#ef5350
    style MTOR fill:#ef5350
    style STAT3 fill:#4a1a6b
    style JUN fill:#4a1a6b
    style NRF2 fill:#4a1a6b
    style GBM fill:#5d4400
    style LC3 fill:#6d3b00
    style SQSTM1 fill:#6d3b00

Tumor Necrosis Factor (Tnf) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Tumor Necrosis Factor (TNF) is a pro-inflammatory cytokine that plays a central role in the immune response and has emerged as a critical mediator in neurodegenerative diseases.^{1TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease2008 · J Neuroinflammation · DOI 10.1186/1742-2094-5-45Open reference} Originally discovered for its ability to induce tumor cell death, TNF is now recognized as a key driver of neuroinflammation—a hallmark feature of Alzheimer’s disease, Parkinson’s disease, ALS, and other neurodegenerative conditions.^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}

Overview

TNF is a 26-kDa transmembrane protein that can be cleaved to form a soluble 17-kDa trimeric cytokine.^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference} It signals through two distinct receptors: ^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}

• TNF Receptor 1 (TNFR1/p55): Expressed ubiquitously, mediates most inflammatory effects

• TNF Receptor 2 (TNFR2/p75): Expressed primarily on immune cells and endothelial cells

The balance between soluble TNF (sTNF) and transmembrane TNF (tmTNF), as well as receptor usage, determines the biological outcome of TNF signaling.^{4The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor1995 · Cell · DOI 10.1016/0092-8674(95Open reference}

TNF Signaling Pathways

Classical (TNFR1) Signaling

TNFR1 activation triggers two major signaling cascades: ^{5TNF receptor 2 pathway: drug target for autoimmune diseases2010 · Nat Rev Drug Discov · DOI 10.1038/nrd3130Open reference}

Pro-inflammatory Pathway

1. NF-κB activation: TNFR1 recruits TRADD, TRAF2, and RIP1, leading to IKK complex activation

2. IκB phosphorylation and degradation: Releases NF-κB to translocate to the nucleus

3. Gene transcription: Induces expression of inflammatory mediators, adhesion molecules, and anti-apoptotic proteins

Apoptotic Pathway

1. Complex II formation: When NF-κB is inhibited, TRADD recruits FADD and caspase-8

2. Caspase cascade: Initiator caspase-8 activates executioner caspases-3, -6, -7

3. Cell death: Apoptosis or necroptosis depending on cellular context

Alternative (TNFR2) Signaling

TNFR2 signaling primarily involves:^{5TNF receptor 2 pathway: drug target for autoimmune diseases2010 · Nat Rev Drug Discov · DOI 10.1038/nrd3130Open reference 6TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects2015 · Neuroscience · DOI 10.1016/j.neuroscience.2015.06.038Open reference}

• TRAF2-mediated NF-κB activation: Leads to anti-apoptotic and proliferative responses

• MAPK activation: JNK and p38 pathways

• Immune cell regulation: Promotes T cell proliferation and survival

Role in Neuroinflammation

CNS Expression

In the central nervous system, TNF is produced by:^{6TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects2015 · Neuroscience · DOI 10.1016/j.neuroscience.2015.06.038Open reference 7Microglia protect neurons against ischemia by synthesis of tumor necrosis factor2009 · J Neurosci · DOI 10.1523/JNEUROSCI.5505-08.2009Open reference}

• Microglia: The primary resident immune cells of the brain

• Astrocytes: Reactive astrocytes in pathological states

• Neurons: Under certain conditions, neurons can produce TNF

• Endothelial cells: Of the blood-brain barrier

Microglial Activation

TNF is a key driver of microglial activation:^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}0 ^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}1

1. Pro-inflammatory phenotype: TNF stimulates microglia to produce IL-1β, IL-6, and more TNF

2. Phagocytosis modulation: Alters microglial clearance functions

3. Cytotoxicity: Can contribute to neuronal injury through oxidative stress

Blood-Brain Barrier Permeability

TNF increases blood-brain barrier (BBB) permeability:^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}2 ^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}3

• Endothelial activation: Upregulates adhesion molecules (VCAM-1, ICAM-1)

• Tight junction disruption: Modifies claudin-5, occludin expression

• Leukocyte trafficking: Facilitates peripheral immune cell infiltration

TNF in Neurodegenerative Diseases

Alzheimer’s Disease

TNF is elevated in Alzheimer’s disease and contributes to:^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}4 ^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}5

• Amyloid-β toxicity: TNF enhances neuronal vulnerability to amyloid-beta

• Synaptic dysfunction: Impairs long-term potentiation (LTP)

• Tau pathology: Promotes tau phosphorylation and spreading

• Neuroinflammation: Perpetuates chronic microglial activation

Clinical Evidence

• CSF TNF levels: Elevated in AD patients, correlating with disease severity

• Post-mortem studies: High TNF expression in AD brain tissue

• Genetic associations: TNF polymorphisms linked to AD risk

Parkinson’s Disease

TNF plays a significant role in dopaminergic neuron degeneration:^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}6 ^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}7

• Nigral vulnerability: TNF is highly expressed in the substantia nigra of PD patients

• Glial activation: Activates microglia surrounding dopaminergic neurons

• α-Synuclein interaction: May promote α-synuclein aggregation

Evidence

• CSF and plasma: Elevated TNF in PD patients

• Genetic studies: TNF polymorphisms associated with PD risk

• Animal models: TNF overexpression reproduces parkinsonian features

Amyotrophic Lateral Sclerosis (ALS)

TNF contributes to motor neuron injury:^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}8 ^{2Systemic infections and inflammation affect chronic neurodegeneration2007 · Nat Rev Immunol · DOI 10.1038/nri2015Open reference}9

• Motor neuron toxicity: Direct toxic effects on motor neurons

• Glial involvement: Activates astrocytes and microglia

• Excitotoxicity: Modulates glutamate signaling

Multiple Sclerosis

TNF is implicated in demyelination:^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}0 ^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}1

• Demyelination: Promotes oligodendrocyte death

• Autoimmunity: Drives T cell-mediated autoimmune responses

• BBB disruption: Facilitates immune cell infiltration

Therapeutic Targeting

TNF Inhibitors

Several strategies have been explored to modulate TNF signaling in neurodegeneration: ^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}2

Biological Agents

| Agent | Target | Status | Notes | ^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}3 |-------|--------|--------|-------| | Etanercept | sTNF/TNFR1 | Clinical trials | Soluble receptor fusion protein | | Infliximab | TNF | Clinical trials | Monoclonal antibody | | Adalimumab | TNF | Preclinical | FDA-approved for autoimmune diseases | | Lenercept | TNF | Clinical trials | PEGylated TNF receptor |

Blood-Brain Barrier Penetration Challenge

A major challenge is achieving sufficient CNS penetration:^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}4

• Peripheral vs. central effects: Systemic TNF blockade may not adequately target CNS

• Receptor selectivity: TNFR1-selective inhibitors may be preferable

• Novel delivery: Focused ultrasound, nanoparticles under investigation

Alternative Approaches

Small Molecule Inhibitors

• Thalidomide and analogs: Inhibit TNF production

• Phosphodiesterase inhibitors: Reduce TNF expression

• MAPK inhibitors: Target upstream signaling

Gene Therapy

• TNF siRNA: Knockdown of TNF expression

• TNF decoy receptors: Viral delivery of TNFR2 variants

Genetic Associations

TNF Gene Polymorphisms

The TNF gene (6p21.33) has several polymorphisms that affect expression:^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}5

• TNF-308 G>A (rs1800629): High producer allele, linked to various diseases

• TNF-238 G>A (rs361525): Modulates TNF expression

• Extended haplotypes: Combined with HLA alleles

Disease Associations

TNF and Brain Development

Beyond pathology, TNF has physiological roles in the CNS:^{3The TNF and TNF receptor superfamilies: integrating mammalian biology2001 · Cell · DOI 10.1016/S0092-8674(01Open reference}6

Synaptic Plasticity

• LTP regulation: Bidirectional effects depending on concentration

• Synaptic scaling: Involved in homeostatic plasticity

• Learning and memory: Modulates cognitive function

Neurogenesis

• Adult neurogenesis: Influences neural stem cell proliferation

• Cell fate decisions: Can promote astrocytic differentiation

Measurement and Biomarkers

Detection Methods

• ELISA: Quantifies soluble TNF in CSF, plasma

• Multiplex assays: Measures multiple cytokines simultaneously

• Single molecule array (Simoa): Ultrasensitive detection

Clinical Utility

• Diagnostic biomarker: Elevated TNF in various conditions

• Prognostic marker: Correlates with disease progression

• Therapeutic monitoring: Tracks treatment response

Research Directions

Current Focus Areas

1. Selective TNFR1 inhibitors: Develop drugs that specifically block TNFR1 while preserving TNFR2 signaling

2. BBB-penetrant inhibitors: Novel delivery methods for CNS-targeted therapy

3. Microglial modulation: Targeting TNF production specifically in microglia

4. Personalized medicine: Genetic stratification for TNF-targeted therapy

Clinical Trials

Multiple trials have investigated TNF modulation in neurodegenerative diseases with mixed results. Ongoing research focuses on:

• Early intervention strategies

• Combination therapies

• Biomarker-driven patient selection

See Also

• Interleukin-6 (IL-6)

• Microglia

• Neuroinflammation

• Alzheimer’s Disease

• Parkinson’s Disease

• Blood-Brain Barrier

External Links

• UniProt: TNF (Human)

• IUPHAR: TNF Receptors

• NIH: TNF and Neurodegeneration Research

• Nature Reviews: TNF in Neuroinflammation

Background

The study of Tumor Necrosis Factor (Tnf) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Brain Atlas Resources

• Allen Human Brain Atlas - TNF Expression: Gene expression data in human brain

• Allen Mouse Brain Atlas - TNF: Mouse brain expression patterns

• BrainSpan - Developmental Transcriptome: Developmental expression data